LBWCX
Price
$22.10
Change
-$0.04 (-0.18%)
Updated
Oct 7 closing price
Net Assets
97.67M
RWMHX
Price
$67.22
Change
-$0.17 (-0.25%)
Updated
Oct 7 closing price
Net Assets
209.3B
Interact to see
Advertisement

LBWCX vs RWMHX

Header iconLBWCX vs RWMHX Comparison
Open Charts LBWCX vs RWMHXBanner chart's image
BrandywineGLOBAL Div US Large Value C
Price$22.10
Change-$0.04 (-0.18%)
VolumeN/A
Net Assets97.67M
American Funds Washington Mutual R5E
Price$67.22
Change-$0.17 (-0.25%)
VolumeN/A
Net Assets209.3B
LBWCX vs RWMHX Comparison Chart in %
View a ticker or compare two or three
VS
LBWCX vs. RWMHX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LBWCX is a Buy and RWMHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWMHX has more cash in the bank: 209B vs. LBWCX (97.7M). RWMHX pays higher dividends than LBWCX: RWMHX (1.33) vs LBWCX (0.65). LBWCX was incepted earlier than RWMHX: LBWCX (15 years) vs RWMHX (10 years). LBWCX (1.91) is less costly to investors than RWMHX (0.41). LBWCX is a more actively managed with annual turnover of: 75.00 vs. RWMHX (29.00). RWMHX has a lower initial minimum investment than LBWCX: RWMHX (250) vs LBWCX (1000). RWMHX annual gain was more profitable for investors over the last year : 6.94 vs. LBWCX (2.04). RWMHX return over 5 years is better than : 52.00 vs. LBWCX (34.28).
LBWCXRWMHXLBWCX / RWMHX
Total Expense Ratio1.900.41463%
Annual Report Gross Expense Ratio1.910.41466%
Fund Existence15 years10 years-
Gain YTD11.76210.618111%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets97.7M209B0%
Annual Yield % from dividends0.651.3349%
Returns for 1 year2.046.9429%
Returns for 3 years28.1245.5262%
Returns for 5 years34.2852.0066%
Returns for 10 years26.70N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XFOR3.440.07
+2.08%
X4 Pharmaceuticals Inc
PERI9.63-0.15
-1.53%
Perion Network Ltd
ALB90.53-1.50
-1.63%
Albemarle Corp
UK0.95-0.05
-5.25%
Ucommune International Ltd
ADNT24.29-1.49
-5.78%
Adient plc